129 related articles for article (PubMed ID: 7298794)
1. Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells.
Cote PJ; Fernie BF; Ford EC; Shih JW; Gerin JL
J Virol Methods; 1981 Oct; 3(3):137-47. PubMed ID: 7298794
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
Orvell C; Norrby E; Mufson MA
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
[TBL] [Abstract][Full Text] [Related]
3. The characterization and uses of monoclonal antibodies to respiratory syncytial virus.
Stott EJ; Bew MH; Taylor G; Jebbett J; Collins AP
Dev Biol Stand; 1984; 57():237-44. PubMed ID: 6084614
[TBL] [Abstract][Full Text] [Related]
4. The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescence.
Routledge EG; McQuillin J; Samson AC; Toms GL
J Med Virol; 1985 Mar; 15(3):305-20. PubMed ID: 3884736
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins.
Kim HW; Wyatt RG; Fernie BF; Brandt CD; Arrobio JO; Jeffries BC; Parrott RH
J Clin Microbiol; 1983 Dec; 18(6):1399-404. PubMed ID: 6361054
[TBL] [Abstract][Full Text] [Related]
6. Antigen mimicry involving measles virus hemagglutinin and human respiratory syncytial virus nucleoprotein.
Norrby E; Sheshberadaran H; Rafner B
J Virol; 1986 Jan; 57(1):394-6. PubMed ID: 2416956
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus.
Kennedy HE; Jones BV; Tucker EM; Ford NJ; Clarke SW; Furze J; Thomas LH; Stott EJ
J Gen Virol; 1988 Dec; 69 ( Pt 12)():3023-32. PubMed ID: 3199102
[TBL] [Abstract][Full Text] [Related]
8. Bovine respiratory syncytial virus-specific monoclonal antibodies.
Klucas CA; Anderson GA
Vet Immunol Immunopathol; 1988 Jun; 18(4):307-15. PubMed ID: 3046116
[TBL] [Abstract][Full Text] [Related]
9. A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.
Samson AC; Willcocks MM; Routledge EG; Morgan LA; Toms GL
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1479-83. PubMed ID: 3755162
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates.
Gimenez HB; Cash P; Melvin WT
J Gen Virol; 1984 May; 65 ( Pt 5)():963-71. PubMed ID: 6202832
[TBL] [Abstract][Full Text] [Related]
11. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities.
Hendry RM; Fernie BF; Anderson LJ; Godfrey E; McIntosh K
J Immunol Methods; 1985 Mar; 77(2):247-58. PubMed ID: 3981003
[TBL] [Abstract][Full Text] [Related]
13. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
J Virol; 2017 May; 91(10):. PubMed ID: 28275185
[TBL] [Abstract][Full Text] [Related]
14. The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications.
Wu B
Clin Lab Med; 1985 Sep; 5(3):589-613. PubMed ID: 3899483
[TBL] [Abstract][Full Text] [Related]
15. Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein.
Robinson BS; Everson JS
Arch Virol; 1992; 125(1-4):273-86. PubMed ID: 1379425
[TBL] [Abstract][Full Text] [Related]
16. Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo.
Tempest PR; Bremner P; Lambert M; Taylor G; Furze JM; Carr FJ; Harris WJ
Biotechnology (N Y); 1991 Mar; 9(3):266-71. PubMed ID: 1367535
[TBL] [Abstract][Full Text] [Related]
17. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
Palomo C; García-Barreno B; Peñas C; Melero JA
J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.
Tsutsumi H; Flanagan TD; Ogra PL
J Gen Virol; 1987 Aug; 68 ( Pt 8)():2161-7. PubMed ID: 2440982
[TBL] [Abstract][Full Text] [Related]
19. Pneumoviruses: the cell surface of lytically and persistently infected cells.
Parry JE; Shirodaria PV; Pringle CR
J Gen Virol; 1979 Aug; 44(2):479-91. PubMed ID: 118236
[TBL] [Abstract][Full Text] [Related]
20. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
